Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions
- PMID: 26316058
- DOI: 10.4155/tde.15.45
Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions
Erratum in
-
Corrigendum.Ther Deliv. 2016 Jun;7(6):412-6. doi: 10.4155/tde.15.45c1. Ther Deliv. 2016. PMID: 27387066 No abstract available.
Abstract
We have explored for which type of compounds biorelevant dissolution profiling in simulated intestinal fluids would accurately predict solubility in human intestinal fluid. In total, 474 solubility values in simulated and aspirated human intestinal fluid for 78 drugs were compiled and analyzed. Significant solubilization in the colloidal structures was obtained in fasted and fed state fluids for drug compounds with a logD(oct)>3. Highly lipophilic compounds with high melting points (Tm > 200 °C) could also be significantly solubilized, but typically such compounds had solubility values in the lower µg/ml range also in the presence of the colloidal structures. On the basis of our analysis, compounds with a logD(oct)>3 should be explored in biorelevant dissolution media to better predict in vivo performance after oral dosing.
Similar articles
-
Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.Mol Pharm. 2012 Jul 2;9(7):1942-52. doi: 10.1021/mp2006467. Epub 2012 Jun 20. Mol Pharm. 2012. PMID: 22651218
-
Is the full potential of the biopharmaceutics classification system reached?Eur J Pharm Sci. 2014 Jun 16;57:224-31. doi: 10.1016/j.ejps.2013.09.010. Epub 2013 Sep 25. Eur J Pharm Sci. 2014. PMID: 24075971
-
A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.Eur J Pharm Sci. 2014 Jun 16;57:322-32. doi: 10.1016/j.ejps.2013.08.027. Epub 2013 Aug 29. Eur J Pharm Sci. 2014. PMID: 23994640 Review.
-
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13. Mol Pharm. 2016. PMID: 27031624
-
Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.Eur J Pharm Biopharm. 2015 Aug;94:229-40. doi: 10.1016/j.ejpb.2015.05.015. Epub 2015 May 29. Eur J Pharm Biopharm. 2015. PMID: 26032292 Review.
Cited by
-
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report.Mol Pharm. 2024 Aug 5;21(8):3697-3731. doi: 10.1021/acs.molpharmaceut.4c00526. Epub 2024 Jun 30. Mol Pharm. 2024. PMID: 38946085 Free PMC article. Review.
-
Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid.J Phys Chem B. 2017 Dec 7;121(48):10869-10881. doi: 10.1021/acs.jpcb.7b08622. Epub 2017 Nov 21. J Phys Chem B. 2017. PMID: 29090933 Free PMC article.
-
Computational prediction of drug solubility in water-based systems: Qualitative and quantitative approaches used in the current drug discovery and development setting.Int J Pharm. 2018 Apr 5;540(1-2):185-193. doi: 10.1016/j.ijpharm.2018.01.044. Epub 2018 Feb 6. Int J Pharm. 2018. PMID: 29421301 Free PMC article. Review.
-
Food effect risk assessment in preformulation stage using material sparing μFLUX methodology.ADMET DMPK. 2022 Oct 7;10(4):299-314. doi: 10.5599/admet.1476. eCollection 2022. ADMET DMPK. 2022. PMID: 36578564 Free PMC article.
-
Molecular Dynamics Simulations on Interindividual Variability of Intestinal Fluids: Impact on Drug Solubilization.Mol Pharm. 2020 Oct 5;17(10):3837-3844. doi: 10.1021/acs.molpharmaceut.0c00588. Epub 2020 Sep 4. Mol Pharm. 2020. PMID: 32787279 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical